You got a question regarding our products, ordering or shipping conditions?
Please send us an e-mail or give us a call.

Phone:      +49 6151 3251-00 or

Below you find some frequently asked questions.

Q: How can I order Zedira products?
A: Just fill in the order-sheet and send it via Fax or attached to an e-mail. Zedira delivers its products all over the world.

Q: Which methods of payment are accepted?
A: We accept credit card payment. Mostly, payment is made via bank transfer. All required information is listed on the order-sheet.

Q: Why has my product been sent at ambient temperature, although the storage condition is indicated to be below e.g. -18°C?
A: Most of our products are freeze dried and stable at ambient temperature for several days. Therefore shipment can be made at ambient temperature with no loss in activity. However, we strongly recommend long term storage as indicated.

Q: How do I handle a product after storage below room temperature?
A: When taking the product out of the fridge or freezer, wait until it reaches room temperature before opening.

Q: How do I reconstitute a lyophilised product?
A: We recommend adding exactly the volume of water the product is lyophilized from. You find this information on the certificate of analysis. Rotate vial gently until solid dissolves.

Q: How can I store a product after reconstitution? How long can I store the product, and how many freeze-thaw cycles are recommended?    
A: These questions are very product-specific. First of all we refer to the product data sheets and the information given for the specific product.
Generally, we recommend short term storage cooled on ice after reconstitution of the protein. To avoid freeze-thaw cycles, we strongly recommend storage of aliquots.

Q: What means the product status “available”?
A: The product in question is on stock and ready for shipment within 1 day. Dependent on the destination shipment will be made on the following Monday.

Q: What means the product status “on request”?
A: The product in question is not on stock. The product will be produced on demand or is under development. Please contact us for product specific details.

Q: What is the shelf life of a product?
A: If not indicated otherwise, we guarantee shelf life after purchase of at least 6 months without loss of performance. After that period, we recommend testing the product before use. Expiration dates of products with short shelf life can be found on the Certificate of Analysis enclosed to your delivery.


  • Zedira offers a huge portfolio of reliable specialist transglutaminase related products meant to catalyze research and development, both in academia and industry.


  • imageReversibly acting transglutaminase 2 inhibitors: drug candidates for the treatment of fibrosis
  • Zedira supports Gordon Research Conference
  • imagePress release: Zedira announces ISO 9001:2015 certification
  • imageZedira communication: Joint poster presentation on “Feasibility of a new automated FXIII activity assay”
  • imageArtikel in DZG Aktuell 01/2019 über die klinische Wirksamkeitsstudie unseres potentiellen Zöliakie Medikaments (deutsch)
  • imagePreview: Catalogue Editorial 2019
  • Press release: Dr. Falk Pharma and Zedira announce start of the phase 2a proof of concept study of ZED1227 for the treatment of celiac disease
  • Artikel in DLG-Lebensmittel – 06/2017 zur Bestimmung von Transglutaminase in Lebensmitteln (deutsch)
  • Zedira publication: Microbial Transglutaminase Used in Bread Preparation at Standard Bakery Concentrations Does Not Increase Immunodetectable Amounts of Deamidated Gliadin
  • Pressemitteilung: Dr. Falk Pharma und Zedira geben den Abschluss der Phase 1b-Studie für ZED1227 zur Zöliakie-Therapie bekannt und planen Start der Wirksamkeitsstudie
  • Press release: Dr. Falk Pharma and Zedira announce completion of phase 1b clinical trial of ZED1227 for the treatment of celiac disease and move on to proof of concept study
  • Press Release: Dr. Falk Pharma GmbH and Zedira enter a phase 1b clinical trial for a celiac disease drug
  • Zedira publication: Microbial transglutaminase has a lower deamidation preference than human tissue transglutaminase on a celiac disease relevant wheat gliadin T-cell epitope
  • Press release: Additional subsidy funding for clinical development of a celiac disease drug
  • Pressemitteilung: Zusätzliche Fördermittel für die klinische Entwicklung eines Zöliakie-Medikamentes
  • Press Release: Cooperation between Zedira and Cardiff University - Transglutaminase 6 is the focus of new research into ataxia
  • Press Release: Dr. Falk Pharma and Zedira enter phase I clinical trials for a celiac disease drug
  • Press release: Zedira receives further funding to develop Factor XIIIa-blockers for safe anticoagulation



  • 19th International Celiac Disease Symposium

    14.10.2021 - 17.10.2021
    Sorrento, Italy

  • Gordon Research Conference: Transglutaminases in Human Disease Processes

    12.06.2022 - 17.06.2022
    Mount Snow, USA